Bio-Rad Laboratories Inc. Class A (NYSE: BIO) stock closed at 351.55 per share at the end of the most recent trading day (a -1.92% change compared to the prior day closing price) with a volume of 123.37K shares and market capitalization of 10.19B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8000 people. Bio-Rad Laboratories Inc. Class A CEO is Norman Schwartz.

The one-year performance of Bio-Rad Laboratories Inc. Class A stock is -17.83%, while year-to-date (YTD) performance is -16.4%. BIO stock has a five-year performance of 14.81%. Its 52-week range is between 344.63 and 509.6225, which gives BIO stock a 52-week price range ratio of 3.49%

Bio-Rad Laboratories Inc. Class A currently has a PE ratio of -2.10, a price-to-book (PB) ratio of 1.48, a price-to-sale (PS) ratio of 5.09, a price to cashflow ratio of 47.80, a PEG ratio of 0.40, a ROA of -41.67%, a ROC of -47.65% and a ROE of -56.29%. The company’s profit margin is -69.91%, its EBITDA margin is -273.90%, and its revenue ttm is $2.07 Billion , which makes it $83.72 revenue per share.

Of the last four earnings reports from Bio-Rad Laboratories Inc. Class A, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $2.87 for the next earnings report. Bio-Rad Laboratories Inc. Class A’s next earnings report date is 26th Oct 2023.

The consensus rating of Wall Street analysts for Bio-Rad Laboratories Inc. Class A is Strong Buy (1.25), with a target price of $621.67, which is +76.99% compared to the current price. The earnings rating for Bio-Rad Laboratories Inc. Class A stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bio-Rad Laboratories Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bio-Rad Laboratories Inc. Class A has a Sell technical analysis rating based on Technical Indicators (ADX : 9.51, ATR14 : 8.85, CCI20 : -93.78, Chaikin Money Flow : -0.19, MACD : -8.30, Money Flow Index : 61.01, ROC : -5.82, RSI : 36.62, STOCH (14,3) : 12.18, STOCH RSI : 0.47, UO : 40.93, Williams %R : -87.82), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bio-Rad Laboratories Inc. Class A in the last 12-months were: Ajit Ramalingam (Sold 0 shares of value $0 ), Ajit Ramalingam (Sold 396 shares of value $166 315 ), Crowley Michael (Sold 500 shares of value $189 695 ), Dara Wright (Option Excercise at a value of $0), Daskal Ilan (Sold 0 shares of value $0 ), Ernst Timothy (Option Excercise at a value of $167 819), Ernst Timothy (Sold 1 746 shares of value $849 300 ), Ilan Daskal (Option Excercise at a value of $0), Last Andrew (Sold 0 shares of value $0 ), Timothy S. Ernst (Option Excercise at a value of $167 819), Timothy S. Ernst (Sold 1 746 shares of value $849 300 )